Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab175636-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $89.90 | |
Ab175636-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $419.90 | |
Ab175636-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,089.90 | |
Ab175636-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,749.90 |
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Product Name | Quilizumab (anti-IgE) - Primary antibody, specific to IGHE, Human IgG1 |
---|---|
Synonyms | Igh2 antibodyIGHE antibody | IGHEP1 antibody | Immunoglobulin heavy constant epsilon antibody | IgE | immunoglobulin heavy constant epsilon | Anti-Human NGcGM3 Recombinant Antibody |
Specifications & Purity | ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
Host species | Human |
Specificity | IGHE |
Conjugation | Unconjugated |
Grade | Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
Action Type | INHIBITOR |
Mechanism of action | Antibody of immunoglobulin heavy constant epsilon |
Product Description | Quilizumab (anti-IgE) is a humanized IgG1κ monoclonal antibody. Quilizumab (anti-IgE) targets the M1-prime segment of membrane-expressed IgE, leading to depletion of IgE-switched and memory B cells. Quilizumab (anti-IgE) has the potantial for the asthma research. |
Isotype | Human IgG1 |
---|---|
Light Chain Type | kappa |
SDS-PAGE | 146.5 kDa |
Purification Method | Protein A purified |
Form | Liquid |
Concentration | Lot by Lot |
Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
Shipped In | Ice chest + Ice pads |
Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
CAS | 1228538-47-3 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IMGT/mAb-DB | 406 |
---|
Enter Lot Number to search for COA:
1. Gauvreau GM, Harris JM, Boulet LP, Scheerens H, Fitzgerald JM, Putnam WS, Cockcroft DW, Davis BE, Leigh R, Zheng Y et al.. (2014) Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production.. Sci Transl Med, 6 (243): (243ra85). [PMID:24990880] [10.1021/op500134e] |
2. Pennington LF, Gasser P, Brigger D, Guntern P, Eggel A, Jardetzky TS. (2021) Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions.. J Allergy Clin Immunol, 71 (13): (1755-70). [PMID:33991582] [10.1016/j.jaci.2021.03.050] |
3. Kolkhir P, Altrichter S, Munoz M, Hawro T, Maurer M. (2020) New treatments for chronic urticaria.. Ann Allergy Asthma Immunol, 124 (1): (2-12). [PMID:31446134] [10.1021/op500134e] |